Galactorrhea in a 38-Year-Old Woman: Diagnosis and Treatment
Measure serum prolactin and TSH levels immediately, review all medications, and if hyperprolactinemia is confirmed without an obvious medication cause, obtain pituitary MRI to identify a prolactinoma—then treat with cabergoline as first-line therapy.
Diagnostic Evaluation
Initial Laboratory Workup
Start with three essential tests 1, 2:
- Pregnancy test (mandatory in all premenopausal women)
- Serum prolactin level (the key diagnostic test)
- TSH level (hypothyroidism is a reversible cause)
- Renal function tests (chronic kidney disease can cause hyperprolactinemia)
Medication Review
Conduct a thorough medication review before proceeding with imaging, as medication-induced hyperprolactinemia is one of the most common causes 3, 1. The highest-risk medications include:
- Antipsychotics (especially risperidone, which carries the highest risk) 4
- Antidepressants (SSRIs, tricyclics)
- Antiemetics (metoclopramide, domperidone) 5
- Antihypertensives (methyldopa, verapamil)
- Hormone therapies
Critical pitfall: Don't assume galactorrhea is medication-related without imaging if prolactin is significantly elevated or if discharge is unilateral, as this can mask underlying pathology including malignancy 6.
Imaging
Obtain brain MRI with pituitary protocol if 1, 2:
- Prolactin is elevated AND no medication cause is identified
- Prolactin level is markedly elevated (>100 ng/mL suggests macroadenoma; >200 ng/mL strongly suggests it) 3
- Any neurological symptoms are present (headaches, visual changes)
Treatment Algorithm
If Medication-Induced Hyperprolactinemia
First-line approach: Discontinue the offending medication if clinically feasible, or substitute with an agent from the same class that has lower prolactin-elevating potential 3.
If medication cannot be stopped 3:
- Asymptomatic patients: No treatment required
- Symptomatic patients with hypogonadism or low bone mass: Consider estrogen replacement OR cautious dopamine agonist use (requires coordination with prescribing physician, especially for antipsychotics due to risk of psychosis exacerbation)
If Prolactinoma Identified
For symptomatic prolactinomas (micro- or macroadenomas), cabergoline is the definitive first-line treatment 3:
- Cabergoline is superior to bromocriptine with 92-95% normalization of prolactin levels, 86% resolution of galactorrhea, and better tolerability 3
- Dosing: Start 0.25-0.5 mg twice weekly, titrate up to 0.25-3 mg/week (occasionally up to 11 mg/week for resistant cases) 3
- Efficacy: Normalizes prolactin in 92% of microadenomas and 77% of macroadenomas; achieves 90% tumor shrinkage 3
If Microprolactinoma Without Symptoms
Asymptomatic microprolactinomas do not require treatment 3. These rarely grow and can be monitored with periodic prolactin levels.
For women with amenorrhea from microprolactinoma 3:
- Option 1: Dopamine agonist (cabergoline preferred)
- Option 2: Oral contraceptives (less expensive, fewer side effects, but amenorrhea cannot be used to monitor disease)
If Normal Prolactin and TSH
Idiopathic galactorrhea with normal labs 2:
- If not bothersome: Reassure patient, no treatment needed
- If bothersome: Short course of low-dose dopamine agonist usually effective
Follow-Up Protocol
For patients started on dopamine agonist therapy 3:
- Prolactin levels: Check monthly initially to guide dose titration
- MRI: Repeat in 1 year for microadenomas; in 3 months for macroadenomas or if prolactin rises despite treatment
- Visual fields: Monitor in macroadenomas at risk of optic chiasm compression
- Bone density: Assess if prolonged hypogonadism present
Key Clinical Pearls
- Prolactin levels generally correlate with tumor size: Microadenomas typically <100 ng/mL; macroadenomas often >200 ng/mL 3
- Cabergoline has higher affinity for dopamine receptors than bromocriptine, explaining superior efficacy and tolerability 3
- Surgery is rarely needed: Reserved for dopamine agonist resistance (after maximizing tolerable doses) or intolerance 3
- Unilateral discharge warrants heightened suspicion: Even in patients on antipsychotics, persistent unilateral galactorrhea with imaging abnormalities requires tissue diagnosis to exclude malignancy 6